ESQ Esquire beats Q1 estimates with 174 revenue growth but shares decline 16 despite EPS beat What favorite stocks Hims HIMS Declines 20260429 Xenon Pharmaceuticals XENE Unveils Robust Azetukalner Phase III Data Q3 NDA Filing Plans at Bloom Burton Conference Flagstar FLG Stock Outlook and Catalysts Q1 2026 EPS Exceeds Expectations How Strawberry STRW manages counterparty exposure Q4 2025 EPS Exceeds Expectations iShares Latin America 40 ETF ILF Leading Emerging Market Thematic Play Outperforms Broader Benchmarks Amid 2026 Market Volatility What RiverNorthDoubleLine OPPB has done differently this quarter Cellectis CLLS Reports Strong Q1 2026 Revenue NA EPS Beats UK Petrol and Diesel Prices Under Pressure as Iran Conflict Weighs on Supply